新型单胺氧化酶A特异性抑制剂CGP 11305 A对健康志愿者单胺氧化酶的抑制作用。 - Suppr | 超能文献

Monoamine oxidase inhibition in healthy volunteers by CGP 11305 A, a new specific inhibitor of MAO-A.

作者信息

Bieck P, Antonin K H, Jedrychowski M

出版信息

Mod Probl Pharmacopsychiatry. 1983;19:53-62. doi: 10.1159/000407503.

DOI:10.1159/000407503

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Monoamine oxidase inhibition in healthy volunteers by CGP 11305 A, a new specific inhibitor of MAO-A.新型单胺氧化酶A特异性抑制剂CGP 11305 A对健康志愿者单胺氧化酶的抑制作用。

Mod Probl Pharmacopsychiatry. 1983;19:53-62. doi: 10.1159/000407503.

2

Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase.

Mod Probl Pharmacopsychiatry. 1983;19:31-52. doi: 10.1159/000407502.

3

Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.苯乙肼和溴法罗明对健康志愿者单胺氧化酶的抑制作用。

Clin Pharmacol Ther. 1989 Mar;45(3):260-9. doi: 10.1038/clpt.1989.26.

4

Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A.用反苯环丙胺和CGP 11305 A治疗的志愿者的O-甲基化儿茶酚胺、酪胺和苯乙胺的尿排泄情况。

Eur J Clin Pharmacol. 1983;25(3):361-8. doi: 10.1007/BF01037949.

5

Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat.急性和慢性溴法罗明治疗对大鼠的可逆性、胺选择性作用。

Life Sci. 1992;51(1):59-66. doi: 10.1016/0024-3205(92)90219-f.

6

[Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].[新型单胺氧化酶-A抑制剂吗氯贝胺、溴法罗明和托洛沙酮与反苯环丙胺在动物实验中的比较：对临床实践的意义]

Psychiatr Prax. 1989 Aug;16 Suppl 1:18-24.

7

Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.新型单胺氧化酶A可逆性选择性抑制剂CGP 11305 A对大鼠脑内生物胺水平及代谢的影响

Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(1):20-6. doi: 10.1007/BF00647833.

8

Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects.口服酪胺升压试验与单胺氧化酶抑制药物的安全性：健康受试者中溴法罗明与反苯环丙胺的比较

J Clin Psychopharmacol. 1988 Aug;8(4):237-45.

9

Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.用选择性单胺氧化酶抑制剂和选择性5-羟色胺摄取阻滞剂LM 5008处理的大鼠的行为多动

Br J Pharmacol. 1983 Jul;79(3):765-70. doi: 10.1111/j.1476-5381.1983.tb10015.x.

10

Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats.单胺氧化酶抑制剂对未麻醉大鼠的一些心血管作用。

Clin Exp Pharmacol Physiol. 1985 Mar-Apr;12(2):161-8. doi: 10.1111/j.1440-1681.1985.tb02319.x.

引用本文的文献

1

Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029).在使用雷帕霉素（NW-1029）治疗期间，口服酪胺和单胺氧化酶抑制后的升压反应。

Neurotox Res. 2013 May;23(4):315-26. doi: 10.1007/s12640-012-9344-5. Epub 2012 Aug 8.

2

Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A.用反苯环丙胺和CGP 11305 A治疗的志愿者的O-甲基化儿茶酚胺、酪胺和苯乙胺的尿排泄情况。

Eur J Clin Pharmacol. 1983;25(3):361-8. doi: 10.1007/BF01037949.

3

Intravenous amine pressor tests in healthy volunteers. Within- and between subject variances and sex differences.健康志愿者的静脉注射胺类升压药试验。受试者内和受试者间的差异以及性别差异。

Eur J Clin Pharmacol. 1992;42(2):137-41. doi: 10.1007/BF00278472.